{"name":"ETH Zurich","slug":"eth-zurich","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQR0duQl9vS3dnbDhzNXVsSV9uVXpHTTJqM3lNUzkyaW5fdVJUYTk0XzNZQl9LdGVSX2Z3YTg5elA5WDU2QVpYR3VVQnVIdTVLRTVUNEZhbmR2enhRUFlTMkFKY0lOcnNzV1FGWm0yRlR0VXYtczZFcGFxaFhzZlFTc3VxdE9xSko5RDJzN1R6bmUwcGkzN19FYnlsdlJsT2dfUkhhQkF5THVoNURHSFc2VFdWMHZLTzNLSUN0amR6VmdOZjZVcTU0NWlZSzdxQmhhTkRrZ09EZw?oc=5","date":"2026-02-27","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Closing the information gap: ETH Zürich team integrates function and binding in one drug screening assay - drugdiscoverytrends.com","headline":"Closing the information gap: ETH Zürich team integrates function and binding in one drug screening assay","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNaVdXbmstZHJkZGVfUi16SzdIMnBMX1hWeXEzYmFKa0tVRnZqN0FxRUxRUXR5NThPS1lERzNNMEVuOUw0UzJCNVNzTW9jbjNMNWdjWEh5QkQyMlczM01SeUU1T0J0bm5qNnVTRGtqc0FLc2djMWc5WERrRjlkaVozVmZJYmN2R3FDS01HUDB5NXM0NXBLWUJ4MXpkSHhGQlQ5MjhPMlFxMmJRd3Z0MG5pa2JGdVM?oc=5","date":"2026-02-13","type":"pipeline","source":"pharmaphorum","summary":"A fast start to 2026 signals continued investor confidence in Swiss life sciences - pharmaphorum","headline":"A fast start to 2026 signals continued investor confidence in Swiss life sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE93VXNPN291eS1LMllqbkRGWGpvZnlVZWpNS2dfdEh6SUhTdFJCdkp2VjBJQUxrTXdNLVAxM1NjWXliZHdjalN2c1dudlhWbzB2UDNF?oc=5","date":"2025-12-11","type":"pipeline","source":"FirstWord Pharma","summary":"DISCO closes €36M seed as Takeda vet takes helm to lead ADC push - FirstWord Pharma","headline":"DISCO closes €36M seed as Takeda vet takes helm to lead ADC push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPTzhOeEZyVm8tTmx2cEs5czZEbU1qTmxTclVYSHo3aTNtSk5QYlpRbFBiQ1dINnB1YmNoejVPTEwzUE91bEE3U3d6ZXphOWFEVGc0ZGF4X1NZeDNnMGdmTFMxQm9Xd2J4WHhzODZMVjBJbEw2eFhoYjFQRHlKbXBYM2M5elZNWjc0N2lJUlVsX2Q0eU5UTjRKc2hBVmZVMHpBeVB4RXZteVdUbXR2NEt0NjVrU0FiX0ZoTThhNFZsMWNCRHM1QUhpcTdrMWVqbFFCUXYtQzBZYl9wWjhnVHU0bEV5MEJMWlJPdDhyRXYzSTV2Z2prZXc?oc=5","date":"2025-11-14","type":"regulatory","source":"KOF Institut","summary":"Switzerland-US Memorandum of Understanding: Relief, but burdens and risks remain significant - KOF Institut","headline":"Switzerland-US Memorandum of Understanding: Relief, but burdens and risks remain significant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQLU5MVjFabVoxVllSeVBsZzAyMFFUVURwWWJ1dkhLVmRGR0V0QVZ1Vk5CTldRdXA4LVJONVlRQ3NxcXJ5N25PSXhpTWhaNC1QT25mVlUwc3QwY3JFWktMWDI4VVhDN25PeUlGR0E1YVJRREQ5YnVVSHhMTGZOcnJPd2RBSWVIeHdCemRhRHMzYTJNejdRSG0xSTNFemxpdw?oc=5","date":"2025-09-25","type":"pipeline","source":"KOF Institut","summary":"The vulnerable crown jewel - KOF Institut","headline":"The vulnerable crown jewel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNdnNiYTFwLXlUQU1sN3Fwdmg5Y3RHZlVFeFVwUmRzNGVOTnFhdEpQTTNIRmZUTHp2dVhrVXk1cXk5dFVnejFIdmgxdjlnUXFxOFp2aDZxMUJtVFJocXRjX0dlaGRFM2NzMmhXNTFjMHNKSTI1V1dhWGZSWmRpRnZxcXBDLW01Z0hMVjRkR1E1R3JxazRXSEpGMG0xMnVfYVhmS1NCR2FJRVJxOURxRkNlT2RrRzJQTG9YZEREWTdiT1ZtMmRiZVZkMDZmTVpxWTFZbzg4RkdB?oc=5","date":"2025-08-01","type":"pipeline","source":"KOF Institut","summary":"Assessment of the Latest 39 per cent Tariff Threat for Switzerland - KOF Institut","headline":"Assessment of the Latest 39 per cent Tariff Threat for Switzerland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9USDRaQnExelgtSjdmVFc2WTlGMEk2QkU2YTFEdTAtU21sVVlJMk1yendrR3lUTWRjQzE2TElkNlBFU2sxUzBVX3JCUERDWVZ4NG53SkNjVVBsR2NPaEZ0azUzdWhlcjNlSVlpd3d3?oc=5","date":"2025-05-19","type":"pipeline","source":"Roche","summary":"Mapping the future of organoids - Roche","headline":"Mapping the future of organoids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE91V2tzSzk2UHRKNjctSHQ5Yktxa1JORkJYZTJBTFZLVmo2UnRzYW1wX2hmQlZ4T0s0RTFNcmRMYzJVakNrWTBzYWI4TTZhSUZ2LTItZTFuY1FkS2JXdXRB?oc=5","date":"2025-05-06","type":"deal","source":"nature.com","summary":"How I honed my biopharma dealmaking and business-development skills after my PhD - nature.com","headline":"How I honed my biopharma dealmaking and business-development skills after my PhD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNNk9jcEJrTnBWQjlIY1hPcXFKeXQxdFBjRHZONkRmdVRRZFJJRWpiNF9MNGd4cHNSbldLNWJZeE5SZVlJUHhkcl92NnNTYnR2c3hMdk16T0JHYWhyZW1EaUlwdUh6N3JXY0RJYmd4aHJCNDFGZjJsWUVuZmtoc2l2M01RLXhVS0d3Slg2UUU2WHV3dWItQ0M0dnlOcw?oc=5","date":"2024-10-07","type":"deal","source":"cen.acs.org","summary":"The great pharmaceutical-academic merger - cen.acs.org","headline":"The great pharmaceutical-academic merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZDVzNUJWUzZNR0ZDOWFha0ZLSWFTRUh0cW5iQXFXbDA2aDlDSHczQTk4NUJkejF2TXBJLUVSdFl2Y21ydlYtTlNvR2JXbV9PcVVBb0syQVlWUlMxMTBzdDh6VGV2dlBsQTZ3aXotVzVrMWN5VVpBN3p6cjBOWmUyOUpDUC1Mdmp5ZWE1UEV2M2stZ3dSN2NGUkg2WVRZUklXb0g1YlRWaFNmdkRCVmNPMjFwVQ?oc=5","date":"2024-04-29","type":"pipeline","source":"PharmaTimes","summary":"ETH Zurich researchers use AI to develop drug molecules based on protein structures - PharmaTimes","headline":"ETH Zurich researchers use AI to develop drug molecules based on protein structures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQcDc1d2pqWi1oTXZfVEhpRXpnc3N1dHhzc3VyU1FwWTFhay1mUmtLb0dkNEY0T2pmRDVQbC00OUc3Q0ZraS0tQVliN1lQMS1KLU5Tb2lJT19vMkE5SDJyajVidVgzX05rWVNaZVhMcXRzdW5mNHYtdWFkLVU0S0VsSXVGYzhCV01mU2tGcUlwZUNURFktN0sxcjUtUQ?oc=5","date":"2024-04-26","type":"pipeline","source":"pharmaphorum","summary":"ETH develops AI algorithm for drug discovery based on 3D protein surface - pharmaphorum","headline":"ETH develops AI algorithm for drug discovery based on 3D protein surface","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWnFVRkRySmFtX3BOeC1LOUJOV2VheXJOMWpOMVg4NGhEWWcyZGJKOHdwMXdOQlpDMEdGSF9XZmU1TXJzSkZKT1pSNWl5ZnVBWWpkdTY4UTN3bE1yeHdTUXpDMDZRSUcwR2cta2ZhNVR3SmJ3QzhLcUNwT0ZST19qelp1ZFRjLTlfd2tMMlZEOW1VVC1XbXhwTUZNaWdmbER4Mk9RMDBDSTZneHNnN05NRXpZQnAya1ZLbTYyV0NfWmlDZw?oc=5","date":"2020-10-19","type":"pipeline","source":"Fierce Pharma","summary":"Good vibrations: ETH Zurich scientists tap ultrasound for targeted drug delivery to the brain - Fierce Pharma","headline":"Good vibrations: ETH Zurich scientists tap ultrasound for targeted drug delivery to the brain","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}